VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 86 of Oncotarget features Figure 6, "Schematic representation of the duality of TXNIP function as it pertains to peritoneal carcinomatosis/sarcomatosis," by Spaeth-Cook, et al.
|
|
Table of Contents
Editorial
|
| Antigenarmed antibodies against Bcell malignancies |
|
https://doi.org/10.18632/oncotarget.26276
|
| 35601-35602 |
|
| B2M JAK2 and MET in the genetic landscape of immunotolerance in lung cancer |
|
https://doi.org/10.18632/oncotarget.26277
|
| 35603-35604 |
|
| Precision virotherapies: Coming soon |
|
https://doi.org/10.18632/oncotarget.26280
|
| 35605-35606 |
|
| Should we measure clonal circulating plasma cells in light chain amyloidosis |
|
https://doi.org/10.18632/oncotarget.26289
|
| 35607-35608 |
|
| Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations |
|
https://doi.org/10.18632/oncotarget.26292
|
| 35609-35610 |
Research Papers
|
| Third party umbilical cord blood derived regulatory Tcells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility safety and immune reconstitution |
|
https://doi.org/10.18632/oncotarget.26242
|
| 35611-35622 |
|
| Prognostic significance of tumor genotypes and CD8+ infiltrates in stage IIII colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26256
|
| 35623-35638 |
|
| DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.26257
|
| 35639-35654 |
|
| Expression of neuropilin1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas |
|
https://doi.org/10.18632/oncotarget.26273
|
| 35655-35665 |
|
| Clinical associations of mucin 1 in human lung cancer and precancerous lesions |
|
https://doi.org/10.18632/oncotarget.26278
|
| 35666-35675 |
|
| Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition |
|
https://doi.org/10.18632/oncotarget.26281
|
| 35676-35686 |
|
| A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2positive breast cancer: the METTEN study |
|
https://doi.org/10.18632/oncotarget.26286
|
| 35687-35704 |
|
| EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients |
|
https://doi.org/10.18632/oncotarget.26298
|
| 35705-35716 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
